Skip to content

Effect of different modalities of perioperative application of dexmedetomidine on postoperative sleep quality in patients undergoing laparoscopic abdominal surgery

Effect of different modalities of perioperative application of dexmedetomidine on postoperative sleep quality in patients undergoing laparoscopic abdominal surgery

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400089184
Enrollment
Unknown
Registered
2024-09-03
Start date
2024-09-07
Completion date
Unknown
Last updated
2024-09-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative sleep disorders

Interventions

Intraoperative continuous intravenous pumping of dexmedetomidine group:Induction of anesthesia: dexmedetomidine 1µg/kg was pumped intravenously within ten minutes, and the rate was adjusted to 0.4ug/k
a postoperative intravenous analgesia pump was connected at the end of the operation, and the analgesia pump was formulated as sufentanil 0.04µg/kg/h, which is the same as dexmedetomidine 0.04µg/kg/h
Postoperative intravenous analgesic pump with dexmedetomidine group:Induction of anesthesia: saline was pumped in at the same rate as the end of intravenous pumping of dexmedetomidine 1µg/kg for ten m
a postoperative intravenous analgesic pump was connected at the end of the surgery, and the analgesic pump was formulated with sufentanil 0.04µ g/kg/h, dexmedetomidine 0.04 µg/kg/h, flurbiprofenate 0.
Intraoperative continuous pumping + dexmedetomidine added to postoperative intravenous analg

Sponsors

Department of Anesthesiology and Surgery, The First Hospital of Lanzhou University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: (1) patients undergoing elective laparoscopic abdominal surgery at the First Hospital of Lanzhou University; (2) aged 18-65 years; and (3) requiring postoperative PCIA;

Exclusion criteria

Exclusion criteria: (1) history of sleep disorder (use of sleep-promoting medications or Stop-bang score =3 in January preoperatively); (2) long-term preoperative use of opioids, sedatives, antidepressants, or anxiolytics; (3) preoperative history of depression, schizophrenia, epilepsy, or Parkinson's disease; inability to provide informed consent (coma, severe dementia, or speech impairment); sick sinus syndrome, sinus bradycardia (6 h; and (7) failure to sign informed consent.

Design outcomes

Primary

MeasureTime frame
Subjective sleep quality on the first postoperative day;

Secondary

MeasureTime frame
Postoperative stress level;Resting pain level on postoperative day 1;sedation level;delirium;Inflammation level on the first postoperative day;

Countries

China

Contacts

Public ContactLiu Yatao

The First Hospital of Lanzhou University

liuyt@lzu.edu.cn+86 139 1945 1548

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026